Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1034820210170020201
Molecular & Cellular Toxicology
2021 Volume.17 No. 2 p.201 ~ p.212
KIF11 inhibition decreases cytopathogenesis and replication of influenza A virus
Kim Dong-In

Kang Ji-Hun
Kim Eui-Ho
Seo Young-Jin
Abstract
Background: Seasonal flu is an infectious disease of the respiratory tract caused by influenza viruses. The development of anti-influenza drugs has significantly reduced the threat from the influenza virus; however, frequent mutations of this negative RNA virus result in antiviral-resistant strains, and constantly intimidate the human race. Thus, identifying novel therapeutic targets for the prevention and treatment of influenza virus infections is critical.

Objective: We aimed to determine whether the kinesin superfamily protein 11 (KIF11) inhibitors, monastrol and K858, inhibit viral cytopathogenesis and influenza A virus (IAV) replication.

Result: When MDCK or HEK293 cells were treated with monastrol and K858 that did not induce significant cytotoxicity, IAV-induced cytopathic effect was attenuated significantly. Furthermore, these inhibitors effectively suppressed the production of viral RNA, proteins, and infectious viral particles.

Conclusion: Inhibition of KIF11 activity effectively attenuates virus-mediated cytopathic effect and suppresses viral replication. Hence, KIF11 is a potential therapeutic target against the influenza virus.
KEYWORD
KIF11, Influenza A virus, Viral cytopathogenesis, Anti-viral drug
FullTexts / Linksout information
Listed journal information